MyFinsight
Home
Blog
About
Contact
Download
Download image
Proceeds from issuance of
common stock,...
$3,025,000
Cash acquired in
acquisition of imgx
$336,427
Net cash provided by
financing activities
$3,025,000
Net cash provided by
investing activities
$336,427
Net (decrease) in
cash, cash...
$2,505,739
Canceled cashflow
$855,688
Accounts payable
$176,463
Other liabilities
$79,795
Prepaid expenses
-$45,984
Deposits
-$1
Net cash used in
operating activities
-$855,688
Canceled cashflow
$302,243
Net loss
-$1,152,810
Accrued expenses
-$5,120
Back
Back
Cash Flow
source: myfinsight.com
Entero Therapeutics, Inc. (ENTO)
Entero Therapeutics, Inc. (ENTO)